
Dr. Konstantinos Hatzinikolas participated in multiple international FDA-approved clinical studies on innovative ophthalmic treatments, including Lumigan, Permavision implants, and therapies for macular degeneration and glaucoma, conducted across UK and Greece with leading institutions.
Read More